O'Connor Daniel J.
CEO at Ambrx Biopharma, Inc.; CEO and President at ONCOSEC MEDICAL Inc; Chief Executive Officer at Advaxis, Inc.
- Sold, on record
- $998k
- Dollars the filings state
- Form 4 sales
- 13
- Latest Oct 27, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- Ambrx Biopharma, Inc.CEO
- ONCOSEC MEDICAL IncCEO and President
- Advaxis, Inc.Chief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Ambrx Biopharma, Inc.50,012 shares
- Advaxis, Inc.42,094 shares
- ONCOSEC MEDICAL Inc20,855 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ONCOSEC MEDICAL IncPlan not statedJan 31, 2020 2020
Sold 2,654 shares at $1.96 ($5k)
O'Connor Daniel J., CEO and President
Sold 3.9% of holdings ($135k position)66,061 shares leftFiling
- 2 Form 4 sale ONCOSEC MEDICAL IncPlan not statedApr 30, 2020 +90 days
Sold 3,075 shares at $1.79 ($6k)
O'Connor Daniel J., CEO and President
Sold 4.7% of holdings ($118k position)62,986 shares leftFiling
- 3 Form 4 sale ONCOSEC MEDICAL IncPlan not statedJul 31, 2020 +92 days
Sold 3,133 shares at $4.20 ($13k)
O'Connor Daniel J., CEO and President
Sold 2.9% of holdings ($458k position)105,962 shares left1.2x usual sizeFiling
- 4 Form 4 sale ONCOSEC MEDICAL IncPlan not statedNov 2, 2020 +94 days
Sold 3,280 shares at $3.79 ($12k)
O'Connor Daniel J., CEO and President
Sold 3.1% of holdings ($402k position)102,682 shares left1.1x usual sizeFiling
- 5 Form 4 sale ONCOSEC MEDICAL IncPlan not statedFeb 1, 2021 +91 days
Sold 3,413 shares at $7.71 ($26k)
O'Connor Daniel J., CEO and President
Sold 3.3% of holdings ($792k position)99,269 shares left1.1x usual sizeFiling
- 6 Form 4 sale ONCOSEC MEDICAL IncPlan not statedApr 30, 2021 +88 days
Sold 3,172 shares at $4.86 ($15k)
O'Connor Daniel J., CEO and President
Sold 3.2% of holdings ($482k position)96,097 shares left1x usual sizeFiling
- 7 Form 4 sale Ambrx Biopharma, Inc.RoutineOct 27, 2023 +910 days
Sold 50,012 shares at $9.82 ($491k)
O'Connor Daniel J., President and CEO
10b5-1 planSold 12.7% of holdings ($3.9M position)342,845 shares leftFirst sale on recordFiling
- 8 Form 144 notice Ambrx Biopharma, Inc.NoticeNov 1, 2023 +5 days
Filed to sell 50,012 shares ($491k)
O'Connor Daniel J., CEO
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 1, 2023 | Nov 1, 2023 | Ambrx Biopharma, Inc. | CEO | Form 144 notice | 50,012 | $491k | Notice | SEC | |
| Oct 27, 2023 | Oct 31, 2023 | Ambrx Biopharma, Inc. | President and CEO | Form 4 sale | 50,012 | $491k | 12.7% | Routine | SEC |
| Apr 30, 2021 | May 4, 2021 | ONCOSEC MEDICAL Inc | CEO and President | Form 4 sale | 3,172 | $15k | 3.2% | Plan not stated | SEC |
| Feb 1, 2021 | Feb 2, 2021 | ONCOSEC MEDICAL Inc | CEO and President | Form 4 sale | 3,413 | $26k | 3.3% | Plan not stated | SEC |
| Nov 2, 2020 | Nov 3, 2020 | ONCOSEC MEDICAL Inc | CEO and President | Form 4 sale | 3,280 | $12k | 3.1% | Plan not stated | SEC |
| Jul 31, 2020 | Aug 4, 2020 | ONCOSEC MEDICAL Inc | CEO and President | Form 4 sale | 3,133 | $13k | 2.9% | Plan not stated | SEC |
| Apr 30, 2020 | May 4, 2020 | ONCOSEC MEDICAL Inc | CEO and President | Form 4 sale | 3,075 | $6k | 4.7% | Plan not stated | SEC |
| Jan 31, 2020 | Feb 3, 2020 | ONCOSEC MEDICAL Inc | CEO and President | Form 4 sale | 2,654 | $5k | 3.9% | Plan not stated | SEC |
| Oct 31, 2019 | Nov 1, 2019 | ONCOSEC MEDICAL Inc | CEO and President | Form 4 sale | 2,128 | $5k | 3.0% | Plan not stated | SEC |
| Nov 2, 2016 | Nov 2, 2016 | Advaxis, Inc. | Chief Executive Officer | Form 4 sale | 8,240 | $69k | 2.7% | Plan not stated | SEC |
| May 2, 2016 | May 2, 2016 | Advaxis, Inc. | Chief Executive Officer | Form 4 sale | 8,237 | $62k | 2.6% | Plan not stated | SEC |
| Jan 29, 2016 | Feb 1, 2016 | Advaxis, Inc. | Chief Executive Officer | Form 4 sale | 8,818 | $61k | 2.7% | Plan not stated | SEC |
| Oct 30, 2015 | Nov 3, 2015 | Advaxis, Inc. | Chief Executive Officer | Form 4 sale | 8,350 | $102k | 2.5% | Plan not stated | SEC |
| Jul 31, 2015 | Aug 4, 2015 | Advaxis, Inc. | Chief Executive Officer | Form 4 sale | 8,449 | $130k | 2.4% | Plan not stated | SEC |